指南与共识消化、代谢与肾脏急症重症综合管理与镇静镇痛

欧洲多学会共识:同时性结直肠癌与肝转移的术语、诊断和管理

The multi-societal European consensus on the terminology, diagnosis and management of patients with synchronous colorectal cancer and liver metastases: an E-AHPBA consensus in partnership with ESSO, ESCP, ESGAR, and CIRSE.
指南 / 共识 · HPB (Oxford) · 2023-07-13
一句话结论E-AHPBA联合ESSO、ESCP、ESGAR和CIRSE发布共识,明确同时性肝转移术语定义并给出诊断与管理框架。

该共识由E-AHPBA联合ESSO、ESCP、ESGAR和CIRSE等多个组织制定,聚焦同时性结直肠癌与肝转移的术语、诊断和管理。共识组提出相关声明,经在线Delphi流程修订,70%及以上同意者进入最终会议讨论,最终形成包含12条关键声明的共识文件。共识明确了同时性肝转移、早期与晚期异时性肝转移及消失性肝转移的定义,并就肿瘤委员会组成、急诊与择期临床评估、系统化疗、同期手术及分期手术路径提供指导。

要点

  • 同时性肝转移定义为原发肿瘤就诊时即发现的肝转移。
  • 早期异时性肝转移指就诊时不存在、但原发肿瘤诊断后12个月内发现的肝转移。
  • 晚期异时性肝转移指原发肿瘤诊断12个月后发现的肝转移。
  • 消失性肝转移指系统化疗后MR扫描上不再可检测的病灶。
  • 共识就肿瘤委员会组成、急诊与择期评估及治疗路径(系统化疗、同期手术、分期手术)提供指导。

适用人群与场景

  • 同时性结直肠癌与肝转移患者。
  • 急诊与择期场景下的临床评估。

诊断标准与关键阈值

  • 同时性肝转移:原发肿瘤就诊时检测到的肝转移。
  • 早期异时性肝转移:就诊时不存在、但原发肿瘤诊断后12个月内检测到的肝转移。
  • 晚期异时性肝转移:原发肿瘤诊断12个月后检测到的肝转移。
  • 消失性肝转移:系统化疗后MR扫描上不再可检测的病灶。

处置流程与药物剂量

  • 治疗路径包括系统化疗、同期手术以及以结直肠或肝脏为导向手术作为第一步的分期手术。
  • 共识就肿瘤委员会的推荐组成提供指导。
  • 共识讨论了肺转移的管理和微创手术的作用。

研究设计与关键结果

  • 该共识为多组织、多学科共识,共识组提出聚焦术语、诊断和管理的声明。
  • 声明经在线Delphi流程修订,70%及以上同意者进入最终会议讨论。
  • 报告迭代通过电子邮件共享,最终形成包含12条关键声明的共识文件。

证据类型、等级与局限

  • 证据类型:多组织、多学科共识(指南)。
  • 共识声明经在线Delphi流程修订,70%及以上同意者纳入最终会议讨论。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 共识推荐为管理同时性结直肠癌与肝转移的临床医生提供实用价值的信息。
  • 共识术语定义(同时性、早期/晚期异时性、消失性肝转移)可用于急诊与择期评估时的统一表述。

指南或共识出处

  • 欧洲多学会共识:同时性结直肠癌与肝转移的术语、诊断和管理(E-AHPBA与ESSO、ESCP、ESGAR和CIRSE合作共识),发表于HPB (Oxford)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Contemporary management of patients with synchronous colorectal cancer and liver metastases is complex. The aim of this project was to provide a practical framework for care of patients with synchronous colorectal cancer and liver metastases with a focus on terminology, diagnosis and management.

METHODS: This project was a multi-organisational, multidisciplinary consensus. The consensus group produced statements which focused on terminology, diagnosis and management. Statements were refined during an online Delphi process and those with 70% agreement or above were reviewed at a final meeting. Iterations of the report were shared by electronic mail to arrive at a final agreed document comprising twelve key statements.

RESULTS: Synchronous liver metastases are those detected at the time of presentation of the primary tumour. The term "early metachronous metastases" applies to those absent at presentation but detected within 12 months of diagnosis of the primary tumour with "late metachronous metastases" applied to those detected after 12 months. Disappearing metastases applies to lesions which are no longer detectable on MR scan after systemic chemotherapy. Guidance was provided on the recommended composition of tumour boards and clinical assessment in emergency and elective settings. The consensus focused on treatment pathways including systemic chemotherapy, synchronous surgery and the staged approach with either colorectal or liver-directed surgery as first step. Management of pulmonary metastases and the role of minimally invasive surgery was discussed.

CONCLUSIONS: The recommendations of this contemporary consensus provide information of practical value to clinicians managing patients with synchronous colorectal cancer and liver metastases.

来源:HPB (Oxford),查看原文。版权归原作者所有。

参考来源

  1. Siriwardena AK, Serrablo A, Fretland ÅA, et al. The multi-societal European consensus on the terminology, diagnosis and management of patients with synchronous colorectal cancer and liver metastases: an E-AHPBA consensus in partnership with ESSO, ESCP, ESGAR, and CIRSE. HPB (Oxford). 2023. PMID: 37471055. doi:10.1016/j.hpb.2023.05.360

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。